Age-Related Macular Degeneration (AMD) Therapeutics Market Report

China Age-Related Macular Degeneration (AMD) Therapeutics Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 25, 2022
  • PAGES：220
  • REPORT CODE：GMM1174800
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Age-Related Macular Degeneration (AMD) Therapeutics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Age-Related Macular Degeneration (AMD) Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Age-Related Macular Degeneration (AMD) Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Bausch Health Companies Inc

    • Amgen Inc

    • Novartis AG

    • F Hoffmann-La Roche Ltd

    • Regeneron Pharmaceuticals Inc

    By Type:

    • Wet AMD

    • Dry AMD

    By End-User:

    • Hospital

    • Clinic

    • Research Institute

    • Other

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Age-Related Macular Degeneration (AMD) Therapeutics Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate of Wet AMD from 2016 to 2027

    • 1.3.2 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate of Dry AMD from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate of Hospital from 2016 to 2027

    • 1.4.2 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate of Clinic from 2016 to 2027

    • 1.4.3 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate of Research Institute from 2016 to 2027

    • 1.4.4 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Age-Related Macular Degeneration (AMD) Therapeutics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Age-Related Macular Degeneration (AMD) Therapeutics by Major Types

    • 3.4.1 Market Size and Growth Rate of Wet AMD

    • 3.4.2 Market Size and Growth Rate of Dry AMD

    4 Segmentation of Age-Related Macular Degeneration (AMD) Therapeutics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Age-Related Macular Degeneration (AMD) Therapeutics by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Age-Related Macular Degeneration (AMD) Therapeutics in Hospital

    • 4.4.2 Market Size and Growth Rate of Age-Related Macular Degeneration (AMD) Therapeutics in Clinic

    • 4.4.3 Market Size and Growth Rate of Age-Related Macular Degeneration (AMD) Therapeutics in Research Institute

    • 4.4.4 Market Size and Growth Rate of Age-Related Macular Degeneration (AMD) Therapeutics in Other

    5 Market Analysis by Regions

    • 5.1 China Age-Related Macular Degeneration (AMD) Therapeutics Production Analysis by Regions

    • 5.2 China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis

    • 6.1 North China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis by Major Types

    • 6.2 North China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis by Major End-Users

    7 Central China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis

    • 7.1 Central China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis by Major Types

    • 7.2 Central China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis by Major End-Users

    8 South China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis

    • 8.1 South China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis by Major Types

    • 8.2 South China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis by Major End-Users

    9 East China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis

    • 9.1 East China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis by Major Types

    • 9.2 East China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis by Major End-Users

    10 Northeast China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis

    • 10.1 Northeast China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis by Major Types

    • 10.2 Northeast China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis by Major End-Users

    11 Southwest China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis

    • 11.1 Southwest China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis by Major Types

    • 11.2 Southwest China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis by Major End-Users

    12 Northwest China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis

    • 12.1 Northwest China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis by Major Types

    • 12.2 Northwest China Age-Related Macular Degeneration (AMD) Therapeutics Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Bausch Health Companies Inc

      • 13.1.1 Bausch Health Companies Inc Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Amgen Inc

      • 13.2.1 Amgen Inc Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Novartis AG

      • 13.3.1 Novartis AG Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 F Hoffmann-La Roche Ltd

      • 13.4.1 F Hoffmann-La Roche Ltd Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Regeneron Pharmaceuticals Inc

      • 13.5.1 Regeneron Pharmaceuticals Inc Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate of Wet AMD from 2016 to 2027

    • Figure China Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate of Dry AMD from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate of Hospital from 2016 to 2027

    • Figure China Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate of Clinic from 2016 to 2027

    • Figure China Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate of Research Institute from 2016 to 2027

    • Figure China Age-Related Macular Degeneration (AMD) Therapeutics Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Age-Related Macular Degeneration (AMD) Therapeutics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Age-Related Macular Degeneration (AMD) Therapeutics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Age-Related Macular Degeneration (AMD) Therapeutics by Different Types from 2016 to 2027

    • Table Consumption Share of Age-Related Macular Degeneration (AMD) Therapeutics by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Wet AMD

    • Figure Market Size and Growth Rate of Dry AMD

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Age-Related Macular Degeneration (AMD) Therapeutics by Different End-Users from 2016 to 2027

    • Table Consumption Share of Age-Related Macular Degeneration (AMD) Therapeutics by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Research Institute

    • Figure Market Size and Growth Rate of Other

    • Table China Age-Related Macular Degeneration (AMD) Therapeutics Production by Regions

    • Table China Age-Related Macular Degeneration (AMD) Therapeutics Production Share by Regions

    • Figure China Age-Related Macular Degeneration (AMD) Therapeutics Production Share by Regions in 2016

    • Figure China Age-Related Macular Degeneration (AMD) Therapeutics Production Share by Regions in 2021

    • Figure China Age-Related Macular Degeneration (AMD) Therapeutics Production Share by Regions in 2027

    • Table China Age-Related Macular Degeneration (AMD) Therapeutics Consumption by Regions

    • Table China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Regions

    • Figure China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Regions in 2016

    • Figure China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Regions in 2021

    • Figure China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Regions in 2027

    • Table North China Age-Related Macular Degeneration (AMD) Therapeutics Consumption by Types from 2016 to 2027

    • Table North China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure North China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2016

    • Figure North China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2021

    • Figure North China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2027

    • Table North China Age-Related Macular Degeneration (AMD) Therapeutics Consumption by End-Users from 2016 to 2027

    • Table North China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure North China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2016

    • Figure North China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2021

    • Figure North China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2027

    • Table Central China Age-Related Macular Degeneration (AMD) Therapeutics Consumption by Types from 2016 to 2027

    • Table Central China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Central China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2016

    • Figure Central China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2021

    • Figure Central China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2027

    • Table Central China Age-Related Macular Degeneration (AMD) Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Central China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2016

    • Figure Central China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2021

    • Figure Central China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2027

    • Table South China Age-Related Macular Degeneration (AMD) Therapeutics Consumption by Types from 2016 to 2027

    • Table South China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure South China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2016

    • Figure South China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2021

    • Figure South China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2027

    • Table South China Age-Related Macular Degeneration (AMD) Therapeutics Consumption by End-Users from 2016 to 2027

    • Table South China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure South China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2016

    • Figure South China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2021

    • Figure South China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2027

    • Table East China Age-Related Macular Degeneration (AMD) Therapeutics Consumption by Types from 2016 to 2027

    • Table East China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure East China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2016

    • Figure East China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2021

    • Figure East China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2027

    • Table East China Age-Related Macular Degeneration (AMD) Therapeutics Consumption by End-Users from 2016 to 2027

    • Table East China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure East China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2016

    • Figure East China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2021

    • Figure East China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2027

    • Table Northeast China Age-Related Macular Degeneration (AMD) Therapeutics Consumption by Types from 2016 to 2027

    • Table Northeast China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2016

    • Figure Northeast China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2021

    • Figure Northeast China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2027

    • Table Northeast China Age-Related Macular Degeneration (AMD) Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Northeast China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2016

    • Figure Northeast China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2021

    • Figure Northeast China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2027

    • Table Southwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption by Types from 2016 to 2027

    • Table Southwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2016

    • Figure Southwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2021

    • Figure Southwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2027

    • Table Southwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Southwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2016

    • Figure Southwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2021

    • Figure Southwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2027

    • Table Northwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption by Types from 2016 to 2027

    • Table Northwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2016

    • Figure Northwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2021

    • Figure Northwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by Types in 2027

    • Table Northwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Northwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2016

    • Figure Northwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2021

    • Figure Northwest China Age-Related Macular Degeneration (AMD) Therapeutics Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Bausch Health Companies Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bausch Health Companies Inc

    • Figure Sales and Growth Rate Analysis of Bausch Health Companies Inc

    • Figure Revenue and Market Share Analysis of Bausch Health Companies Inc

    • Table Product and Service Introduction of Bausch Health Companies Inc

    • Table Company Profile and Development Status of Amgen Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc

    • Figure Sales and Growth Rate Analysis of Amgen Inc

    • Figure Revenue and Market Share Analysis of Amgen Inc

    • Table Product and Service Introduction of Amgen Inc

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of F Hoffmann-La Roche Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd

    • Table Product and Service Introduction of F Hoffmann-La Roche Ltd

    • Table Company Profile and Development Status of Regeneron Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Regeneron Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Regeneron Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Regeneron Pharmaceuticals Inc

    • Table Product and Service Introduction of Regeneron Pharmaceuticals Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US